Polysaccharides from Millettia speciosa Champ. alleviate obesity-associated metabolic dysfunction through the 'gut microbiota-leptin' axis

The roots of <em>Millettia speciosa </em>Champ., a medicinal-edible plant, contain bioactive polysaccharides (MSCPs) that demonstrate potential prebiotic effects. Studies in diet-induced obese (DIO) mice have shown that MSCPs can modulate gut microbiota dysbiosis, suppress appetite, and ultimately alleviate obesity.<em> </em>However, the mechanism by which MSCPs regulate appetite and ameliorate obesity-associated metabolic dysfunction through modulating the gut microbiota still requires further investigation. In this study, we observed that MSCPs improved diet-induced obesity to the same extent as the pair-fed group, suggesting that MSCPs can ameliorate obesity in DIO mice by reducing appetite and energy intake. Through RT-qPCR, Western blot, and immunohistochemical experiments, it was found that MSCPs regulate the expression of appetite-related peptides and activate the JAK2/STAT3 signaling pathway to improve obesity in DIO mice; however, MSCPs did not ameliorate obesity in leptin receptor-deficient (db/db) mice, indicating that the leptin pathway is a critical target for treating DIO mice. Furthermore, MSCPs beneficially modulate gut microbiota; fecal microbiota transplantation experiment (FMT) restored the gut microbiota structure in mice, and the FMT group still alleviated obesity through the same signaling pathway. Additionally, 16S rRNA gene sequencing revealed that both MSCPs and FMT upregulated beneficial microbiota such as Lachnospiraceae_UCG_006 and<em> Faecalibaculum</em>, and promoted the production of short-chain fatty acids (SCFAs).<strong> </strong>Notably, in db/db mice, although MSCPs significantly elevated SCFAs levels, they failed to ameliorate obesity or metabolic disorders, further confirming that the leptin pathway serves as a critical requirement for MSCPs-mediated obesity improvement. In summary, MSCPs may alleviate obesity in DIO mice by enriching Lachnospiraceae_UCG_006 and <em>Faecalibaculum</em> to promote SCFAs production, thereby modulating the leptin pathway.

Authors

Publication Details

Journal
Food Science and Human Wellness
Published
2026-01-01
DOI
https://doi.org/10.26599/fshw.2025.9250874
Primary Topic
Gut microbiota and health
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Polysaccharides from Millettia speciosa Champ. alleviate obesity-associated metabolic dysfunction through the 'gut microbiota-leptin' axis

Caihong Chen, Yanfei Lu, Hao Ran, Jiming Ye et al.
Food Science and Human Wellness
Gut microbiota and health
article

Polysaccharides from Millettia speciosa Champ. alleviate obesity-associated metabolic dysfunction through the 'gut microbiota-leptin' axis

Caihong Chen, Yanfei Lu, Hao Ran, Jiming Ye, Jingwei Jin, Lishe Gan, Zhengrong Wu, Dongli Li, Rihui Wu, Jiaquan Liu
article en

Abstract

The roots of <em>Millettia speciosa </em>Champ., a medicinal-edible plant, contain bioactive polysaccharides (MSCPs) that demonstrate potential prebiotic effects. Studies in diet-induced obese (DIO) mice have shown that MSCPs can modulate gut microbiota dysbiosis, suppress appetite, and ultimately alleviate obesity.<em> </em>However, the mechanism by which MSCPs regulate appetite and ameliorate obesity-associated metabolic dysfunction through modulating the gut microbiota still requires further investigation. In this study, we observed that MSCPs improved diet-induced obesity to the same extent as the pair-fed group, suggesting that MSCPs can ameliorate obesity in DIO mice by reducing appetite and energy intake. Through RT-qPCR, Western blot, and immunohistochemical experiments, it was found that MSCPs regulate the expression of appetite-related peptides and activate the JAK2/STAT3 signaling pathway to improve obesity in DIO mice; however, MSCPs did not ameliorate obesity in leptin receptor-deficient (db/db) mice, indicating that the leptin pathway is a critical target for treating DIO mice. Furthermore, MSCPs beneficially modulate gut microbiota; fecal microbiota transplantation experiment (FMT) restored the gut microbiota structure in mice, and the FMT group still alleviated obesity through the same signaling pathway. Additionally, 16S rRNA gene sequencing revealed that both MSCPs and FMT upregulated beneficial microbiota such as Lachnospiraceae_UCG_006 and<em> Faecalibaculum</em>, and promoted the production of short-chain fatty acids (SCFAs).<strong> </strong>Notably, in db/db mice, although MSCPs significantly elevated SCFAs levels, they failed to ameliorate obesity or metabolic disorders, further confirming that the leptin pathway serves as a critical requirement for MSCPs-mediated obesity improvement. In summary, MSCPs may alleviate obesity in DIO mice by enriching Lachnospiraceae_UCG_006 and <em>Faecalibaculum</em> to promote SCFAs production, thereby modulating the leptin pathway.

Food Science and Human Wellness
Fundo para o Desenvolvimento das Ciências e da Tecnologia, Wuyi University
Affordable and clean energy
Openalex Percentile: Top 95%
Gut microbiota and health
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.